Medicamen Biotech Limited — Others, 13-02-2025: Copy of Newspaper Publication

Medicamen Biotech Limited has announced a board meeting on February 11, 2025, where it approved its financial results for the quarter and nine months ended December 31, 2024. The company shared these results through newspaper publications. This update highlights the company’s continued operational progress, providing insights into its financial health. Investors may view this announcement as a signal of stability, though attention should be maintained on any potential impacts from future market conditions. Overall, a positive outlook can be anticipated as the company is actively engaging with its stakeholders.